Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

OSTEOIMMUNE

Financiado

Cerrado

OSTEOIMMUNE Unraveling the Interactions between the Immune System and Bone

Inflammatory rheumatic diseases affect millions of European citizens causing chronic pain, disability and premature death. Curative treatments are lacking. Conventional research often focuses on one single organ system such as the... ver más

31/05/2016

UNIVERSITATSKLINIK...

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

UNIVERSITATSKLINIKUM JENA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 10 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-05-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

10 Participantes

UNIVERSITATSKLINIKUM JENA

0.00€ | Lider

International Committee of t...

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

RELENT RELapses prevENTion in chronic autoimmune disease common me... 6M€ Cerrado

PREVENTRA Genes environment and immunity in the pathogenesis of rheum... 2M€ Cerrado

SmallDrugRheuma Discovery of Immune Therapeutic Targets and Immunomodulators... 170K€ Cerrado

PRACTICE Prevent Rheumatoid Arthritis in Practice 156K€ Cerrado

PCIN-2017-093 ANTICUERPOS ANTI-FARMACOS Y DETECCION MOLECULAR DE FARMACOS... 121K€ Cerrado

EUTRAIN EUropean TRanslational training for Autoimmunity Immune ma... 4M€ Cerrado

Líder del proyecto

UNIVERSITATSKLINIKUM JENA No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Inflammatory rheumatic diseases affect millions of European citizens causing chronic pain, disability and premature death. Curative treatments are lacking. Conventional research often focuses on one single organ system such as the bone or the immune system and. ignores interactions between organ systems. OSTEOIMMUNE is a supra-disciplinary training network that targets this gap by providing comprehensive, structured and coherent training. The scientific training within OSTEOIMMUNE reflects the participants‘ common research programme aiming to unravel the interactions between the immune system and the skeleton. A group of outstanding European scientists in genetics, (osteo-) immunology, rheumatology and drug development has joined to form OSTEOIMMUNE to provide 12 ESRs and 2 ERs with training in a broad range of laboratory and complementary skills and capacities. OSTEOIMMUNE participants represent 7 of Europe's most active academic centres in arthritis research and 3 highly innovative biotech and pharmaceutical companies. All have contributed important concepts to the field, five groups have earned the title „Centre of excellence. OSTEOIMMUNE participants have an outstanding history of successful collaboration which is reflected in numerous influential joint papers and common efforts in national and European networks (e.g. DFG: IMMUNOBONE, BMBF: IMMUNOPAIN, FP6: EURO-RA, AUTO-CURE, FP7: MASTER-SWITCH) and have trained numerous highly successful ESRs and ERs. Our young investigators will leave the network after successful completion of their training with a set of aptitudes that will enable them to be instrumental in developing curative therapies towards rheumatic diseases, be it in an academic, clinical or industrial setting. Moreover, OSTEOIMMUNE will establish a long-lasting consortium for cutting edge research in the field of osteoimmunology, leading to accelerated and integrated discoveries, which can become commercially exploitable first by European industry.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores